Trials / Conditions / Refractory Endometrial Carcinoma
Refractory Endometrial Carcinoma
3 registered clinical trials studyying Refractory Endometrial Carcinoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors NCT05039801 | M.D. Anderson Cancer Center | Phase 1 |
| Active Not Recruiting | Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer NCT04719273 | Thomas Jefferson University | Phase 2 |
| Active Not Recruiting | A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Re NCT03008408 | M.D. Anderson Cancer Center | Phase 2 |